BILAG GLOSSARY - ResearchGate

The targeted serum urate level was attained on day 28 in 0% of subjects taking placebo and in 56%, 76%, and 94% of those taking febuxostat 40mg, 80mg, or 120mg daily, respectively. The mean serum urate reduction from baseline to day 28 was 2% in the placebo group, and 37% in the 40mg, 44% in the 80mg, and 59% in the 120mg febuxostat groups. ................
................